EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Clinical experience with remimazolam in pediatric anesthesiology: An educational focused review

Joseph D Tobias iD

Pediatric Anesthesia · 2024

DOI: 10.1111/pan.14970 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pediatric Anesthesia, 2024. Verfasst von Joseph D Tobias. Beteiligte Einrichtung: Department of Anesthesiology and Pain Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Benzodiazepines, Hypnotics and Sedatives. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Remimazolam is a novel ultrashort‐acting benzodiazepine, which like midazolam, results in sedation, anxiolysis, and amnesia through its agonistic effects on the gamma‐amino butyric acid A receptor. As opposed to midazolam, its unique metabolism is via tissue esterases, which results in a rapid elimination with a limited context sensitive half‐life and prompt dissipation of its effect when administration is discontinued. Remimazolam received FDA approval for use in adults in 2020. In preliminary and initial clinical trials, its efficacy and safety has been suggested in the adult population, both as a primary agent for procedural sedation or as an adjunct to general anesthesia. There are limited data regarding the use of remimazolam in infants and children and its use in this population remains off label as it does not hold FDA ‐approval in pediatric‐aged patients. This narrative outlines the pharmacologic properties of this unique medication, reviews previous published reports of its role in pediatric‐aged patients, and discusses dosing parameters and clinical use in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzodiazepinesHypnotics and SedativesHumansChildAnesthesiologyPediatricsInfantChild, Preschool

Stichwörter der Autor:innen

benzodiazepinepediatric anesthesiologyprocedural sedationremimazolam

Substanzen

remimazolamBenzodiazepinesHypnotics and Sedatives

Autor:innen und Institutionen

  • Department of Anesthesiology and Pain Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.
  • Department of Anesthesiology and Pain Medicine, The Ohio State University College of Medicine, Columbus, Ohio, USA.
  • Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA.

ORCID-Profile: Joseph D Tobias

Zitieren

APA

Tobias, J. D. (2024). Clinical experience with remimazolam in pediatric anesthesiology: An educational focused review. Pediatric Anesthesia. https://doi.org/10.1111/pan.14970

Vancouver

Tobias JD. Clinical experience with remimazolam in pediatric anesthesiology: An educational focused review. Pediatric Anesthesia. 2024. doi:10.1111/pan.14970

BibTeX
@article{Tobias2024,
  author = {Tobias, Joseph D},
  title = {Clinical experience with remimazolam in pediatric anesthesiology: An educational focused review},
  journal = {Pediatric Anesthesia},
  year = {2024},
  doi = {10.1111/pan.14970}
}
Kostenlos starten →